Tal Patalone

Maccabi HealthCare Services - Kahn Sagol Maccabi (KSM) Research & Innovation Center

SCHOLARLY PAPERS

2

DOWNLOADS

178

SSRN CITATIONS

1

CROSSREF CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

The Effectiveness of the First Dose of BNT162b2 Vaccine in Reducing SARS-CoV-2 Infection: Real-World Evidence

Number of pages: 18 Posted: 20 Jan 2021
Gabriel Chodick, Lilac Tene, Tal Patalone, Sivan Gazit, Amir Ben-Tov, Dani Cohen and Khitam Muhsen
Tel Aviv University - Sackler Faculty of Medicine, Maccabi Institute for Research & Innovation, Maccabi Healthcare Services, Maccabi HealthCare Services - Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Institute for Research & Innovation, Maccabi Healthcare Services, Maccabi Institute for Research & Innovation, Maccabi Healthcare Services, Tel Aviv University and Tel Aviv University - Department of Epidemiology and Preventive Medicine
Downloads 155 (314,358)
Citation 2

Abstract:

Loading...

BNT162b2 vaccine, Effectiveness, SARS-Cov-2, Real-world evidence

2.

Safety of the Fourth COVID-19 BNT162b2 mRNA (Second Booster) Vaccine

Number of pages: 45 Posted: 24 Jun 2022
Matan Yechezkel, Merav Mofaz, Tal Patalone, Sivan Gazit, Erez Shmueli and Dan Yamin
Tel Aviv University - Laboratory for Epidemic Modeling and Analysis, Tel Aviv University - Department of Industrial Engineering, Maccabi HealthCare Services - Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Institute for Research & Innovation, Maccabi Healthcare Services, Tel Aviv University - Department of Industrial Engineering and Tel Aviv University - Department of Industrial Engineering
Downloads 23 (826,167)

Abstract:

Loading...

COVID-19 vaccine, second COVID-19 booster vaccine, BNT162b2, adverse effects, wearable sensors